Use of lhrh antagonists at non-castrating doses

Details Use of lhrh antagonists at non-castrating doses Use of lhrh antagonists at non-castrating doses

A - Human Necessities

61

K

A61K 31/403 (2006.01) A61K 31/416 (2006.01) A61K 31/4412 (2006.01) A61K 31/4439 (2006.01) A61K 31/519 (2006.01) A61K 31/5355 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2716572

The invention relates to medicaments comprising at least one LHRH antagonist, in particular at least one peptidomimetic LHRH antagonist, for use in treatment or prophylaxis of physiological and/or pathological conditions, wherein the at least one LHRH antagonist is to be administered in an intermediate dose, which does not cause chemical (hormonal) castration.

La présente invention concerne des médicaments comprenant au moins un antagoniste du LHRH, en particulier au moins un antagoniste du LHRH peptidomimétique, destiné à être utilisé dans le traitement ou la prophylaxie d'états pathologiques et/ou physiologiques consistant à administrer cet antagoniste du LHRH en une dose intermédiaire n'entraînant acune castration chimique (hormonale).

Affiliated with

Also associated with

Rating

Use of lhrh antagonists at non-castrating doses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of lhrh antagonists at non-castrating doses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lhrh antagonists at non-castrating doses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2067485